These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 392832)

  • 1. Extended treatment with antithymocyte globulin (ATGAM) in renal allograft recipients.
    Wechter WJ; Morrell RM; Bergan J; Rosenberg JC; Turcotte J; Schultz JR
    Transplantation; 1979 Nov; 28(5):365-7. PubMed ID: 392832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antithymocyte globulin (ATGAM) in renal allograft recipients. Multicenter trials using a 14-dose regimen.
    Wechter WJ; Brodie JA; Morrell RM; Rafi M; Schultz JR
    Transplantation; 1979 Oct; 28(4):294-302. PubMed ID: 388762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The adjunctive value of equine antithymocyte membrane globulin in a randomized study of patients undergoing cadaveric renal transplantation.
    Diethelm AG; Blackstone E; Whelchel JD; Pass RF; Chambers L; Phillips SJ; Thiry C
    Transplant Proc; 1979 Mar; 11(1):27-30. PubMed ID: 377644
    [No Abstract]   [Full Text] [Related]  

  • 4. Randomized clinical trial of antithymocyte globulin in cadaver renal allograft recipients: importance of T cell monitoring.
    Cosimi AB; Wortis HH; Delmonico FL; Russell PS
    Surgery; 1976 Aug; 80(2):155-63. PubMed ID: 781887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basiliximab versus antithymocyte globulin for prevention of acute renal allograft rejection.
    Sollinger H; Kaplan B; Pescovitz MD; Philosophe B; Roza A; Brayman K; Somberg K
    Transplantation; 2001 Dec; 72(12):1915-9. PubMed ID: 11773888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapy of acute cadaveric renal allograft rejection with adjunctive antithymocyte globulin.
    Filo RS; Smith EJ; Leapman SB
    Transplantation; 1980 Dec; 30(6):445-9. PubMed ID: 7008293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithymocyte globulin in cadaver renal grafts: prophylaxis and antirejection therapy with three different preparations.
    MacDonald AS; Belitsky P; Lannon SG; Cohen A; White J
    Transplant Proc; 1982 Dec; 14(4):631-4. PubMed ID: 6762719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Minnesota antilymphoblast globulin and Upjohn antithymocyte globulin for induction immunosuppression of human renal allografts.
    Pescovitz MD; Book BK; Milgrom ML; Leapman SB; Petersen B; Filo RS
    Surgery; 1994 Oct; 116(4):811-8. PubMed ID: 7940183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized controlled trial of a monoclonal antibody against the interleukin-2 receptor (33B3.1) as compared with rabbit antithymocyte globulin for prophylaxis against rejection of renal allografts.
    Soulillou JP; Cantarovich D; Le Mauff B; Giral M; Robillard N; Hourmant M; Hirn M; Jacques Y
    N Engl J Med; 1990 Apr; 322(17):1175-82. PubMed ID: 2157982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithymocyte globulin in cadaver kidney transplantation: a randomized trial based on T-cell monitoring.
    Kreis H; Mansouri R; Descamps JM; Dandavino R; N'Guyen AT; Bach JF; Crosnier J
    Kidney Int; 1981 Mar; 19(3):438-44. PubMed ID: 7017244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylaxis of heart transplant rejection with either antithymocyte globulin-, Minnesota antilymphocyte globulin-, or an OKT3-based protocol.
    Ladowski JS; Dillon T; Schatzlein MH; Peterson AC; Deschner WP; Beatty L; Sullivan M; Scheeringa RH; Clark WR
    J Cardiovasc Surg (Torino); 1993 Apr; 34(2):135-40. PubMed ID: 8320247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical evaluation of equine antithymocyte globulin in recipients of renal allografts: Analysis of survival, renal function, rejection, histocompatibility, and complications.
    Diethelm AG; Aldrete JS; Shaw JF; Cobbs CG; Hartley MW; Sterling WA; Morgan JM
    Ann Surg; 1974 Jul; 180(1):20-8. PubMed ID: 4599406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group.
    Sollinger HW
    Transplantation; 1995 Aug; 60(3):225-32. PubMed ID: 7645033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-lymphocyte subsets in renal allograft recipients treated with cyclosporine and azathioprine.
    Sumpio BE; Dwyer JM; Flye MW
    Ann Surg; 1987 Jan; 205(1):49-53. PubMed ID: 3541801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muromonab-CD3 and antithymocyte globulin in renal transplantation.
    Burk ML; Matuszewski KA
    Ann Pharmacother; 1997 Nov; 31(11):1370-7. PubMed ID: 9391693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized clinical trial of antithymocyte globulin induction in renal transplantation comparing a fixed daily dose with dose adjustment according to T cell monitoring.
    Abouna GM; al-Abdullah IH; Kelly-Sullivan D; Kumar MS; Loose J; Phillips K; Yost S; Seirka D
    Transplantation; 1995 Jun; 59(11):1564-8. PubMed ID: 7778170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of delayed cyclosporin A in after administration of anti-lymphocyte serum in kidney transplantation].
    Hourmant M; Soulillou JP
    Biomed Pharmacother; 1987; 41(5):247-9. PubMed ID: 3311191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary immunosuppression with mycophenolate mofetil and antithymocyte globulin for kidney transplant recipients of a suboptimal graft.
    Grinyó JM; Gil-Vernet S; Seron D; Hueso M; Fulladosa X; Cruzado JM; Moreso F; Fernandez A; Torras J; Riera L; Castelao AM; Alsina J
    Nephrol Dial Transplant; 1998 Oct; 13(10):2601-4. PubMed ID: 9794567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advantage of antithymocyte globulin induction in sensitized kidney recipients: a randomized prospective study comparing induction with and without antithymocyte globulin.
    Thibaudin D; Alamartine E; de Filippis JP; Diab N; Laurent B; Berthoux F
    Nephrol Dial Transplant; 1998 Mar; 13(3):711-5. PubMed ID: 9550651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pharmacoeconomic comparison of antithymocyte globulin and muromonab CD3 induction therapy in renal transplant recipients.
    Brennan DC; Schnitzler MA; Baty JD; Ceriotti CS; Lowell JA; Shenoy S; Howard TK; Woodward RS
    Pharmacoeconomics; 1997 Mar; 11(3):237-45. PubMed ID: 10165313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.